Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Accured Expenses: 2016-2025

Historic Change in Accured Expenses for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to -$67,251.

  • cbdMD's Change in Accured Expenses rose 95.73% to -$67,251 in Q3 2025 from the same period last year, while for Sep 2025 it was -$261,883, marking a year-over-year increase of 76.70%. This contributed to the annual value of -$261,883 for FY2025, which is 76.70% up from last year.
  • As of Q3 2025, cbdMD's Change in Accured Expenses stood at -$67,251, which was down 181.51% from $82,503 recorded in Q2 2025.
  • cbdMD's Change in Accured Expenses' 5-year high stood at $763,157 during Q2 2021, with a 5-year trough of -$1.6 million in Q3 2024.
  • In the last 3 years, cbdMD's Change in Accured Expenses had a median value of -$67,251 in 2025 and averaged -$246,852.
  • Per our database at Business Quant, cbdMD's Change in Accured Expenses slumped by 1,494.93% in 2023 and then skyrocketed by 20,577.44% in 2025.
  • cbdMD's Change in Accured Expenses (Quarterly) stood at -$127,254 in 2021, then soared by 130.81% to $39,204 in 2022, then soared by 262.95% to $142,292 in 2023, then crashed by 266.40% to -$236,770 in 2024, then skyrocketed by 95.73% to -$67,251 in 2025.
  • Its Change in Accured Expenses stands at -$67,251 for Q3 2025, versus $82,503 for Q2 2025 and -$40,365 for Q1 2025.